Cisplatin‐resistant osteosarcoma cell‐derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801‐dependent manner
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin‐resistant osteosarcoma cell‐derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801‐dependent manner
Authors
Keywords
-
Journal
CELL BIOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-16
DOI
10.1002/cbin.11532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer
- (2020) Xinyi Wang et al. Molecular Oncology
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Circular RNA circ_001621 promotes osteosarcoma cells proliferation and migration by sponging miR-578 and regulating VEGF expression
- (2020) Xianglu Ji et al. Cell Death & Disease
- Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer
- (2020) Guojun Wu et al. Molecular Therapy-Nucleic Acids
- Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B
- (2020) Jun Cui et al. Aging-US
- Deep Insights in Circular RNAs: from biogenesis to therapeutics
- (2020) Peerzada Tajamul Mumtaz et al. BIOLOGICAL PROCEDURES ONLINE
- Circular RNA hsa_circ_0085131 is involved in cisplatin‐resistance of non‐small cell lung cancer cells by regulating autophagy
- (2020) Rui Kong CELL BIOLOGY INTERNATIONAL
- CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
- (2020) Lin Dong et al. JOURNAL OF MOLECULAR HISTOLOGY
- Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma
- (2020) Dan Guo et al. ONCOLOGY REPORTS
- Long Non-Coding RNA OIP5-AS1 Knockdown Enhances CDDP Sensitivity in Osteosarcoma via miR-377-3p/FOSL2 Axis
- (2020) Ling Liu et al. OncoTargets and Therapy
- Circ‐RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR ‐140‐5p
- (2020) Hongliang Zang et al. Thoracic Cancer
- CircRNAs: A new perspective of biomarkers in the nervous system
- (2020) Yun Ma et al. BIOMEDICINE & PHARMACOTHERAPY
- The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells
- (2020) Xiaohui Zhang et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways
- (2020) Mohadeseh Esmaeili et al. GENE
- Noncoding RNAs versus Protein Biomarkers in Cardiovascular Disease
- (2020) Christian Schulte et al. TRENDS IN MOLECULAR MEDICINE
- Mitochondrial Genome-Derived circRNA mc-COX2 Functions as an Oncogene in Chronic Lymphocytic Leukemia
- (2020) Zijuan Wu et al. Molecular Therapy-Nucleic Acids
- The novel roles of circRNAs in human cancer
- (2019) Qingfeng Shang et al. Molecular Cancer
- Three isoforms of exosomal circPTGR1 promote hepatocellular carcinoma metastasis via the miR449a–MET pathway
- (2019) Guoying Wang et al. EBioMedicine
- Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
- (2019) Caijun Dong et al. OncoTargets and Therapy
- Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression
- (2019) Yizheng Wu et al. Molecular Cancer
- Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer
- (2019) Yan Gao et al. BioScience Trends
- Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds
- (2018) Ammad Ahmad Farooqi et al. BIOTECHNOLOGY ADVANCES
- A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer
- (2018) Dong Hang et al. Cancer Medicine
- Emerging function and potential diagnostic value of circular RNAs in cancer
- (2018) Xianglun Cui et al. Molecular Cancer
- Emerging Roles of Circular RNAs in Osteosarcoma
- (2018) Chenyu Wang et al. MEDICAL SCIENCE MONITOR
- Circles reshaping the RNA world: from waste to treasure
- (2017) Jing Liu et al. Molecular Cancer
- CircRNA: functions and properties of a novel potential biomarker for cancer
- (2017) Shujuan Meng et al. Molecular Cancer
- Circular RNAs in human cancer
- (2017) Yumin Wang et al. Molecular Cancer
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
- (2017) D. Matthew Gianferante et al. Nature Reviews Endocrinology
- Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy
- (2017) Ji-Feng Xu et al. Oncotarget
- Bone Cancer
- (2017) J. Sybil Biermann et al. Journal of the National Comprehensive Cancer Network
- GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy
- (2016) Mihwa Kim et al. Autophagy
- Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
- (2016) Annette Becker et al. CANCER CELL
- Multimodal transfer of MDR by exosomes in human osteosarcoma
- (2016) ELENA TORREGGIANI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Circular RNA Expression: Its Potential Regulation and Function
- (2016) Julia Salzman TRENDS IN GENETICS
- Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling
- (2015) Jessica M Foley et al. Journal of Translational Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More